Trademarkia Logo

Canada

C$
Trademark Search in Canada
KINGYORK & DESIGN

View On IC.GC.CA

KINGYORK & DESIGN
ABANDONED SECTION 40(3)

on 8 Nov 2017

Last Applicant/ Owned by

TIANJIN KINGYORK GROUP CO. LTD.

No. 109, Bawei RoadHeDong DistrictTianjin

CN

Serial Number

1695765 filed on 29th Sept 2014

KINGYORK & DESIGN

Trademark usage description

(1) medicines for human purposes, namely, medicines for the treatment of cardiovascular and cerebrovascular disease, hypertension, cardiopathy; vitami Read More

Vienna Information

1 . 15 . 23

Vortices, rotary movements, tornadoes -- Note: Not including astronomic orbits (1.13.1), atomic orbits (1.13.1), concentric circles (26.1.4 or 26.1.5) and spirals (26.1.5).Tourbillons, mouvements rotatifs, tornade -- Note: Non compris les orbites astronomiques (1.13.1), les orbites atomiques (1.13.1), les cercles concentriques (26.1.4 ou 26.1.5) et les spirales (26.1.5).

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Classification Information

Class [001]
Chemicals and adhesives

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
(1) Medicines for human purposes, namely, medicines for the treatment of cardiovascular and cerebrovascular disease, hypertension, cardiopathy; vitamin preparations, for use during the pregnancy period and the lactation period, amino acid preparations; corticosteroid drugs; amino acid drugs; medicines for anti-inflammatory; medicines for athlete's foot, sprains, cartilage injuries, stopping bleeding from cuts and grazes; medicines for respiratory system disease, emphysema, cough, bronchial asthma, aspiration pneumonitis, symptomatic sarcoidosis, berylliosis, Loeffler's syndrome not manageable by other means, pneumonia, pulmonary tuberculosis; medicines for arthritis, connective tissue injuries, lumbar muscle strain; medicines for allergic states, allergic rhinitis, serum sickness, drug hypersensitivity reactions, allergic dermatitis; cream and ointment for the treatment of dermatologic diseases, namely, medicines for treating skin diseases, namely warts, seborrheic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes; medicines for post-traumatic osteoarthritis, psoriatic arthritis, ankylosing spondylitis, synovitis of osteoarthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, acute gouty arthritis, epicondylitis; medicines for trichinosis, tuberculous meningitis; medicines for rheumatoid arthritis, including juvenile rheumatoid arthritis; medicines for ophthalmic diseases, allergic corneal marginal ulcers, herpes zoster ophthalmicus, anterior segment inflammation, diffuse posterior uveitis and choroiditis, sympathetic ophthalmia, keratitis, optic neuritis, allergic conjunctivitis, chorioretinitis, iritis and iridocyclitis; medicines for gastrointestinal diseases, ulcerative colitis, regional enteritis; medicines for nervous system, namely pharmaceutical preparations for medical, surgical and biological purposes for the treatment of diseases of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorder, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's disease, cerebral palsy, Parkinson's disease, sleep disorders and arthritis; management of oedema associated with brain tumour, acute exacerbations of multiple sclerosis; medicines for inducing a diuresis; medicines for systemic lupus erythematosus, systemic dermatomyositis (polymyositis), acute rheumatic carditis; medicines for the treatment of herpes; medicines of reduce immunity of human, namely medicines for the treatment of immunological disorders, namely, autoimmune diseases, immunologic deficiency syndromes; medicines for the treatment of cancer; inorganic salts, namely disodium hydrogen phosphate, sodium dihydrogen phosphate; sodium phosphate; steroid hormone products, corticosteroid products, namely pharmaceutical products, namely steroid hormone preparations; medicines for constipation (2) Active pharmaceutical ingredients and intermediates, namely, material, namely pharmaceutical substances for the treatment of cardiovascular and cerebrovasculardisease, hypertension, cardiopathy; material for nutritional purposes, namely pharmaceutical substances of the dietary and nutritional supplements for promoting gastrointestinal health and for the treatment of gastrointestinal disorders; food supplements for promoting gastrointestinal health and for the treatment of gastrointestinal disorders, vitamin preparations, for use during the pregnancy period and the lactation period, amino acid preparations; material for anti-inflammatory, namely pharmaceutical substances for anti-inflammatory; material, namely pharmaceutical substances for the treatment of athlete's foot, sprains, cartilage injuries, stopping bleeding from cuts and grazes; material, namely pharmaceutical substances for respiratory system disease, emphysema, cough, bronchial asthma, aspiration pneumonitis, symptomatic sarcoidosis, berylliosis, Loeffler's syndrome not manageable by other means, pneumonia, pulmonary tuberculosis; material, namely pharmaceutical substances for arthritis, connective tissue injuries, lumbar muscle strain; material, namely pharmaceutical substances for the treatment of allergic states, allergic rhinitis, serum sickness, drug hypersensitivity reactions, allergic dermatitis; material, namely pharmaceutical substances for the treatment of dermatologic diseases, namely medicines for treating skin diseases, namely warts, genital warts, Bowen's disease, aktinic keratosis, seborrheic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes, chilblain, contact dermatitis, atopic dermatitis, allergic dermatitis, bullous dermatitis herpetiformis, severe erythema multiforme (Stevens-Johnson syndrome), severe seborrheic dermatitis, exfoliative dermatitis, mycosis fungoides;post-traumatic osteoarthritis, psoriatic arthritis, ankylosing spondylitis, synovitis of osteoarthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, acute gouty arthritis, epicondylitis; material, namely, pharmaceutical substances for trichinosis, tuberculous meningitis; material, namely pharmaceutical substances for rheumatoid arthritis, including juvenile rheumatoid arthritis; material, namely pharmaceutical substances for ophthalmic diseases, allergic corneal marginal ulcers, herpes zoster ophthalmicus, anterior segment inflammation, diffuse posterior uveitis and choroiditis, sympathetic ophthalmia, keratitis, optic neuritis, allergic conjunctivitis, chorioretinitis, iritis and iridocyclitis; material, namely, pharmaceutical substances for gastrointestinal diseases, ulcerative colitis, regional enteritis; material for nervous system, namely pharmaceutical substances for medical, surgical and biological purposes for the treatment of diseases of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorder, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's disease, cerebral palsy, Parkinson's disease, sleep disorders and arthritis; management of oedema associated with brain tumour, acute exacerbations of multiple sclerosis; material, namely pharmaceutical substances for inducing a diuresis; material, namely, pharmaceutical substances for collagen diseases, systemic lupus erythematosus, systemic dermatomyositis (polymyositis), acute rheumatic carditis; material, namely, pharmaceutical substances for treating skin diseases, namely, herpes; material of reduce immunity of human, namely pharmaceutical substances for the treatment of immunological disorders, namely, autoimmune diseases, immunologic deficiency syndromes, aspergillosis; material, namely, pharmaceutical substances for the treatment of cancer; inorganic salts, namely disodium hydrogen phosphate, sodium dihydrogen phosphate; sodium phosphate; material for constipation, namely pharmaceutical substances for the treatment of digestive system diseases, namely, constipation (3) Dressings, namely, surgical, wound; pesticides; insecticides; poison, namely, insect, lice, rat; acaricides; fumigants, namely, for insect infestation, for rodent infestation; repellents, namely, insect, rodent; nutraceuticals or neutraceuticals, namely, meal replacement bars, soy beverages, vitamins, amino acid; fat emulsion and minerals; sanitizers, namely, air, all purpose, hand; Air fresheners; Deodorizers, namely, air, room (4) Chinese Medicine Nostrum, namely, herbal products, namely, extracts of Chinese herbs in individual and compound form, namely traditional Chinese medicines derived from Chinese medical herbs for the treatment of inflammation, namely the heart, liver, kidneys, lungs and stomach, colds, influenza, fever, carbuncles, cough, asthma, diarrhea, fracture, injury, burns, heart trouble, cancer, tonic, medicines for the treatment of anemia; dietary and nutritional supplements, namely herbal extracts in the form of capsules, pills, drinks, granules and tablets, namely traditional Chinese pharmaceuticals for use in the treatment of anxiety, duodenal ulcer, eczema, dermatitis, insomnia, tuberculosis, rhinitis, tracheitis, pneumonia, asthma, esophagitis, enteritis, hepatitis, cardiovascular disease, theumatic arthritis, anemia, apoplexy, heat stroke, cancer, influenza, cough, fever, rubella, poliomyelitis, dysentery, malaria, tonsillitis, laryngitis, pharyngitis, trachoma, conjunctivitis, headache, sprain, bruise, eczema, dermatitis, duodenal ulcer, traditional Chinese medicines derived from Chinese medical herbs for the treatment of inflammation, namely the heart, liver, kidneys, lungs and stomach, colds, influenza, fever, carbuncles, cough, asthma, diarrhea, fracture, injury, burns, heart trouble, cancer, tonic, medicines for the treatment of anemia; Chinese herb-based pharmaceutical tablets and liquids for promoting general well-being, namely for the treatment of diseases of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorder, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's disease, cerebral palsy, Parkinson's disease, sleep disorders and arthritis; traditional Chinese medicine, namely Hawthorne Fruit, Salvia Root, Notoginseng Root, Eucommia Bark, Ginseng Root and Cornsilk; medicines for constipation.

Classification kind code

10

Mark Details

Serial Number

1695765

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 15th Dec 2016		Approved
Submitted for opposition 27
on 24th Oct 2016		Approval Notice Sent
Submitted for opposition 23
on 7th Apr 2016		Default Removed
Submitted for opposition 15
on 7th Apr 2016		Correspondence Created
Submitted for opposition 14
on 24th Nov 2015		Default Notice Sent
Submitted for opposition 22
on 1st May 2015		Search Recorded
Submitted for opposition 20
on 1st May 2015		Examiner's First Report
Submitted for opposition 31
on 1st Oct 2014		Formalized
Submitted for opposition 30
on 29th Sept 2014		Filed
Submitted for opposition 1
on 29th Sept 2014		Created